MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 194 filers reported holding MEDICINES CO in Q4 2018. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $82,137,000 | +119.0% | 967,000 | +28.9% | 4.64% | +70.8% |
| Q3 2019 | $37,500,000 | +37.1% | 750,000 | 0.0% | 2.72% | +15.6% |
| Q2 2019 | $27,353,000 | +63.1% | 750,000 | +25.0% | 2.35% | +21.3% |
| Q1 2019 | $16,770,000 | +277.7% | 600,000 | +158.6% | 1.94% | +253.2% |
| Q4 2018 | $4,440,000 | -89.4% | 232,000 | -83.4% | 0.55% | -88.2% |
| Q3 2018 | $41,874,000 | -8.7% | 1,400,000 | +12.0% | 4.65% | -10.5% |
| Q2 2018 | $45,875,000 | +11.4% | 1,250,000 | 0.0% | 5.19% | +18.2% |
| Q1 2018 | $41,175,000 | +100.8% | 1,250,000 | +66.7% | 4.40% | +17.3% |
| Q4 2017 | $20,505,000 | -38.5% | 750,000 | -16.7% | 3.75% | -50.6% |
| Q3 2017 | $33,336,000 | -27.8% | 900,000 | -25.9% | 7.59% | -30.9% |
| Q2 2017 | $46,182,000 | -22.3% | 1,215,000 | 0.0% | 10.98% | -15.4% |
| Q1 2017 | $59,414,000 | +111.4% | 1,215,000 | +46.7% | 12.98% | +19.4% |
| Q4 2016 | $28,109,000 | +6.4% | 828,198 | +18.3% | 10.87% | -8.2% |
| Q3 2016 | $26,418,000 | – | 700,000 | – | 11.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elk Creek Partners, LLC | 123,624 | $3,513,000 | 1.51% |
| PointState Capital LP | 2,376,414 | $67,538,000 | 1.07% |
| J. Goldman & Co LP | 422,250 | $12,000,000 | 0.88% |
| ASHFORD CAPITAL MANAGEMENT INC | 160,675 | $4,566,000 | 0.88% |
| SECTOR GAMMA AS | 127,550 | $3,625,000 | 0.87% |
| Rock Springs Capital Management LP | 120,000 | $3,410,000 | 0.79% |
| Decatur Capital Management, Inc. | 95,225 | $2,706,000 | 0.52% |
| ROYCE & ASSOCIATES LP | 6,115,200 | $173,794,000 | 0.51% |
| Zweig-DiMenna Associates LLC | 293,500 | $8,341,000 | 0.49% |
| WEXFORD CAPITAL LP | 188,030 | $5,344,000 | 0.41% |